We assessed the survival of 83 patients who received radiotherapy with known IDH1 gene status in our center, and the results showed better OS and PFS for WHO grade 4 IDH-mutant astrocytoma. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).